Middle East And Africa Thyroid Eye Disease Market Size & Outlook, 2026-2034


Middle East And Africa Thyroid Eye Disease Market Insights

  • As highlighted in Reed Intelligence analysis, the Middle East And Africa Thyroid Eye Disease Market, valued at USD 99.47 Million in 2025, is estimated to achieve USD 179.04 Million by 2034.
  • The market is estimated to grow at a CAGR of 6.74% spanning 2026 to 2034.
  • By market size, Biologics led the Therapy Type category in 2025.
  • The Therapy Type segment led by Biologics is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • Middle East And Africa held 8.43% share of the global Thyroid Eye Disease Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, Saudi Arabia is anticipated to record the highest growth in Middle East and Africa, with the market size expected to reach USD 37.94 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 99.47 Million
Market Size In 2034 USD 179.04 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.74% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports